Joining Ichnos as CEO represented a once-in-a-lifetime opportunity to connect all the dots in my career from both a scientific and business perspective
In Conversation
I won’t understate how challenging working in behavioural health is. It’s underfunded and underrecognized. But there is real potential here, and a real urgent need to…
AAM’s policies are consistent with this administration's agenda. We have already had good conversations with the Biden transition team, even before he was sworn in as…
The main obstacle for any research-based pharmaceutical company in this region is the complex regulatory environment
When we look at the immunology field, and you look at certain areas like atopic dermatitis, it's really interesting to see how the launch of new…
The more I discovered the market needs in the orphan business, the more I got passionate about it; I realized we could do something great for…
Collaboration has always been critical, and our connectivity has enabled us to build strong partnerships to achieve mutually beneficial outcomes
A 2019 study of the European Commission ranked Ticino as the second most innovative system (after Zurich) within over 238 European regions
The world is changing very rapidly, COVID or not, and we need to constantly adapt, whether to a changing portfolio, a new business environment, or the…
I tend to use the idea of diagnostics being forgotten in the basement as an analogy because that is typically where hospital labs are located. However,…
For small- to mid-sized pharma companies, M&A might be a much better way to build a portfolio quickly and with less risk
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine, the numerous applications of…
